Data presentation and consumer confidence Date: July 20, 2010 ... According to a new study in the Journal of Consumer Research, data presented in the frequency format leads to more accurate judgments.

Kazia Therapeutics Limited (NASDAQ: KZIA), an oncology-focused drug development company, is pleased to announce the presentation of data highlighting promising clinical activity of EVT801 in high ...

- Oral Presentation on In Vivo Gene Therapy Product Candidate and Data on Gene Editing Candidate Paved Way for Initiation of juMPStart and pheEDIT Trials - BEDFORD, Mass., Oct. 20, 2021 (GLOBE ...

SAN DIEGO and TORONTO, May 14, 2025 (GLOBE NEWSWIRE) — Aptose Biosciences Inc. (“Aptose” or the “Company”) (TSX: APS; OTC: APTOF), a clinical-stage precision oncology company, today announced that ...

CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung ...

Aptose is developing TUS+VEN+AZA as a one-of-a-kind safe and mutation agnostic frontline triple drug therapy for newly diagnosed AML; Oral presentation at EHA will include updated data at the 40 ...

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 2025 ... Nucleic Acids Research, Physical Review, American Chemical Society journals, ...

CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 2025 20 May 2025. MOUNT LAUREL, N.J. ... Nucleic Acids Research, Physical Review, ...